Abstract
To evaluate the pharmacokinetics and pharmacodynamics of different doses of glucagon administered subcutaneously (s.c.) at different blood glucose levels. This study was an open-label, randomized, three-period, cross-over experiment in 6 patients with type 1 diabetes. During each of the three periods, different blood glucose levels were established in four consecutive steps (8, 6, 4 and 2.8 mmol/l) and glucagon was given at each blood glucose level in doses from 0.11 to 0.44 mg and 0.33, 0.66 and 1 mg at the lowest glucose concentration. Maximum glucagon concentration and area under the curve increased with increasing glucagon dose. Maximum glucagon concentration was reached after 10-20 min. Glucagon raised blood glucose in a dose-dependent manner at different baseline blood glucose levels. The median glucose excursion ranged from 2.6 to 6.2 mmol/l. Time to maximum glucose concentration was dose-dependent for the glucagon doses at 2.8 mmol/l, with median values from 40 to 80 min. Glucagon administered s.c. produces a stable pharmacokinetic and pharmacodynamic response at lower doses than the usual rescue dose and across a range of hypo- to hyperglycaemic blood glucose levels. This supports the use of small glucagon doses in the...Continue Reading
References
Jul 1, 1991·Diabetologia·L OrskovO Schmitz
Oct 9, 1999·Journal of Pharmaceutical Sciences·M Yazdanian
Oct 9, 1999·Journal of Pharmaceutical Sciences·C J GrafR Lynch
Apr 24, 2001·Diabetes Care·M W Haymond, B Schreiner
Mar 3, 2006·Journal of Paediatrics and Child Health·Mary HartleyAndrew M Cotterill
Apr 12, 2007·Diabetes Technology & Therapeutics·Firas H El-KhatibEdward R Damiano
Mar 25, 2010·Diabetes Care·Jessica R CastleW Kenneth Ward
Dec 7, 2010·Journal of Diabetes Science and Technology·Steven J RussellEdward R Damiano
Dec 7, 2010·Journal of Diabetes Science and Technology·Jessica R CastleW Kenneth Ward
Aug 28, 2012·Diabetes Care·Steven J RussellEdward R Damiano
Jan 30, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Ahmad HaidarRémi Rabasa-Lhoret
Nov 15, 2013·Diabetes Technology & Therapeutics·Arianne C van BonJ Hans DeVries
Dec 20, 2013·Journal of Diabetes Science and Technology·Ahmad HaidarRémi Rabasa-Lhoret
Jan 15, 2014·European Journal of Endocrinology·Monika J BakJens J Holst
Feb 4, 2014·The Journal of Clinical Endocrinology and Metabolism·Firas H El-KhatibEdward R Damiano
Aug 21, 2014·Diabetes Care·Joseph El YoussefW Kenneth Ward
Citations
Mar 22, 2016·Diabetes, Obesity & Metabolism·H BlauwUNKNOWN , on behalf of the PCDIAB consortium
Oct 19, 2016·Biomarkers in Medicine·Nicolai J Wewer AlbrechtsenJens J Holst
Nov 1, 2016·ACS Chemical Biology·Piotr A MrozRichard D DiMarchi
Sep 16, 2016·Diabetes, Obesity & Metabolism·Nadine TalebRémi Rabasa-Lhoret
Jan 18, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·T M Peters, A Haidar
Dec 24, 2017·Diabetes Care·Ulrike HövelmannTim Heise
Jan 9, 2016·Diabetes, Obesity & Metabolism·A RanjanK Nørgaard
Oct 21, 2017·Diabetes, Obesity & Metabolism·Cristina B GuzmanEric Sicard
Oct 24, 2018·Diabetes, Obesity & Metabolism·Ulrike HövelmannTim Heise
Nov 30, 2018·BMJ Open Diabetes Research & Care·Ilze Dirnena-FusiniSverre Christian Christiansen
Sep 19, 2017·Basic & Clinical Pharmacology & Toxicology·Ajenthen RanjanKirsten Nørgaard
Aug 15, 2020·Scientific Reports·Marte Kierulf ÅmSverre Christian Christiansen
Jun 28, 2017·Journal of Diabetes Science and Technology·Sabrina Lyngbye WendtJohn Bagterp Jørgensen
Oct 17, 2018·Pharmaceutical Research·Jens Kvist MadsenDaniel E Otzen
Sep 29, 2019·Diabetes Technology & Therapeutics·Christian LaugesenAjenthen G Ranjan
Apr 9, 2020·Expert Opinion on Pharmacotherapy·Shujuan LiLi Wang
Nov 1, 2016·Diabetes Care·Ajenthen RanjanKirsten Nørgaard
Dec 19, 2020·Diabetes, Obesity & Metabolism·Christian LaugesenAjenthen G Ranjan
Jan 26, 2020·Endocrinology and Metabolism Clinics of North America·Leah M WilsonJessica R Castle
Oct 23, 2020·Diabetes/metabolism Research and Reviews·Ajenthen G RanjanKirsten Nørgaard
Jun 9, 2021·European Journal of Drug Metabolism and Pharmacokinetics·Ingrid Anna TeigenSverre Christian Christiansen
Jul 16, 2021·Artificial Organs·Marco InfanteCamillo Ricordi